Concepedia

Michèle Haumont

MH

Statistics

Publications

15

Citations

1.2K

H-Index

15

Active since

1993

Affiliations

Université Libre de Bruxelles(Current)

Novasep (Belgium)

UCLouvain

University of Liège

Cliniques Universitaires Saint-Luc

Michèle Haumont is an author at Université Libre de Bruxelles specializing in life sciences, immunology, and infectious diseases.

Publications per year

1993–2008

15

Publications

15

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

Étienne Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen et al. · The Journal of Infectious Diseases · 2007 · 424 citations · Full text

, , +15

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults

Michel Moutschen, Philippe Léonard, Étienne Sokal et al. · Vaccine · 2007 · 179 citations

, , +13

The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans

Alain Jacquet, Ludivine Coulon, Joël De Nève et al. · Molecular and Biochemical Parasitology · 2001 · 135 citations

, , +15

Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model

Michèle Haumont, Louis Delhaye, Lida Garcia et al. · Infection and Immunity · 2000 · 75 citations · Full text

, , +17

The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans

Alain Jacquet, Michèle Haumont, Daya Chellun et al. · Virus Research · 1998 · 56 citations

, , +16

1–5 of 15